Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | EYA2 | O00167 | 1/20 | 0.48 |
| ▸ | APP | P05067 | 1/20 | 0.48 |
| ▸ | ACE | P12821 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 2/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | DRD1 | P21728 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Edetic Acid SCHEMBL9847047 | 1.00 | KDM4E (0.65) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Edetic Acid SCHEMBL9067285 | 0.97 | KDM4E (0.70) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Edetic Acid SCHEMBL8625956 | 0.97 | KDM4E (0.62) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Pentetic Acid SCHEMBL29678762 | 0.97 | KDM4E (0.70) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Edetic Acid SCHEMBL7495735 | 0.97 | KDM4E (0.62) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Edetic Acid SCHEMBL6131131 | 0.97 | KDM4E (0.62) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Edetic Acid SCHEMBL8606974 | 0.97 | KDM4E (0.62) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Pentetic Acid SCHEMBL275096 | 0.97 | KDM4E (0.70) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Edetic Acid SCHEMBL9509467 | 0.97 | KDM4E (0.62) | KDM4EALOX15MAPTSMN1; SMN2TDP1 | |
| Edetic Acid SCHEMBL3821770 | 0.97 | KDM4E (0.62) | KDM4EALOX15MAPTSMN1; SMN2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122076448-A | Sulfur recovery catalyst and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| EP-3508200-B1 | AQUEOUS FORMULATION CONTAINING 5-AMINOLEVULINIC ACID OR THE LIKE | SBI PHARMACEUTICALS CO LTD (JP) | 2024-04-10 | — | — | EP | claimed |
| US-11820974-B1 | Pomegranate molasses medium for culturing microbes | King Faisal University (SA) | 2023-11-21 | — | — | US | claimed |
| CN-215901051-U | Filtering device and filtering unit for ferric ammonium ethylene diamine tetraacetate | 石家庄杰克化工有限公司 | 2022-02-25 | — | — | CN | claimed |
| EP-3168296-B1 | AGENT FOR IMPROVING NORMAL DEVELOPMENT RATE OF FERTILIZED EGGS | SBI PHARMACEUTICALS CO LTD (JP) | 2020-09-09 | — | — | EP | claimed |
| CN-104487066-B | Prophylactic and/or therapeutic agent for radiation damage | 国立大学法人东京大学 | 2020-06-09 | — | — | CN | claimed |
| US-10675242-B2 | Aqueous formulation containing 5-aminolevulinic acid or the like | SBI PHARMACEUTICALS, CO., LTD. (JP) | 2020-06-09 | — | — | US | claimed |
| EP-2767278-B1 | ENHANCER OF SURVIVAL OF TRANSPLANTED ORGAN | SBI PHARMACEUTICALS CO LTD (JP) | 2019-11-06 | — | — | EP | claimed |
| EP-2875812-B1 | PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR RADIATION DAMAGE | UNIV TOKYO (JP) | 2019-09-04 | — | — | EP | claimed |
| EP-3508200-A1 | AQUEOUS FORMULATION CONTAINING 5-AMINOLEVULINIC ACID OR THE LIKE | SBI Pharmaceuticals Co., Ltd. (JP) | 2019-07-10 | — | — | EP | claimed |
| EP-0401147-B1 | A method of chemical-mechanical polishing an electronic component substrate and polishing slurry therefor | IBM (US) | 1995-12-20 | — | — | EP | claimed |
| US-5277775-A | Electrolytic cell for treating PH-adjusted developer and fixer effluents | ENVIRONMENTAL SYSTEMS (INTERNATIONAL) LIMITED (BS) | 1994-01-11 | — | — | US | claimed |
| US-5266121-A | Water, iron salt, chelate compound and silver complexing agent with water rinsing | HELION INDUSTRIES, INC. (US) | 1993-11-30 | — | — | US | claimed |
| WO-1993004985-A1 | SYSTEM FOR TREATMENT OF PHOTOGRAPHIC WASTEWATER EFFLUENT AND PROCESS THEREFOR | NEALE MICHAEL E (CA) | 1993-03-18 | — | — | WO | claimed |
| US-5160417-A | Precipitation of developer, fixer and bleach pollutants | ENVIRONMENTAL SYSTEMS (INTERNATIONAL) LTD. (BS) | 1992-11-03 | — | — | US | claimed |
| US-5084071-A | Etchant and abrasive particles | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1992-01-28 | — | — | US | claimed |
| EP-0401147-A2 | A method of chemical-mechanical polishing an electronic component substrate and polishing slurry therefor | International Business Machines Corporation (US) | 1990-12-05 | — | — | EP | claimed |
| US-4954142-A | Method of chemical-mechanical polishing an electronic component substrate and polishing slurry therefor | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1990-09-04 | — | — | US | claimed |
| US-4293638-A | Method for alleviating partial inactivation of color couplers | EASTMAN KODAK COMPANY (US) | 1981-10-06 | — | — | US | claimed |
| US-4243638-A | Iron EDTA chelate catalyzed oxidation of uranium | WESTINGHOUSE ELECTRIC CORP. (US) | 1981-01-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10675242-B2 | Aqueous formulation containing 5-aminolevulinic acid or the like | ALAD, AAAS, SLC7A5 | KDM4E 448/4885ALOX15 241/4885MAPT 1646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.